06.08.2018
- The European Medicines Agency (EMA) is scaling back and suspending some activities as it loses more staff than initially anticipated in advance of its relocation from the UK to the...
05.07.2018
- The US Food and Drug Administration‘s (FDA) recent approval of a new migraine treatment marketed by Amgen and Novartis has met with an enthusiastic response since it was...
02.07.2018
- In a move that had been widely expected, Swiss drugs giant Novartis has announced that it will spin off its Alcon eye care division into a separate standalone company. The...
24.05.2018
- An ill-advised “advisory” deal with the personal attorney of US president Donald Trump continues to plague Swiss drugmaker Novartis. Two weeks ago the company made headlines when...
19.04.2018
- European drugmakers GlaxoSmithKline of the UK and Novartis of Switzerland have agreed to contribute to a nearly $4 billion global research effort to fight drug-resistant strains of...
11.04.2018
- In an all-cash deal expected to close in the second half of this year, Swiss drugs giant Novartis has agreed to pay $8.7 billion for AveXis, a US-based clinical stage gene therapy...
28.03.2018
- In a move that may explain why GlaxoSmithKline last week turned thumbs down on bidding for Pfizer’s consumer drugs business, the UK’s largest drugmaker has announced plans to buy...
21.11.2017
- European pharmaceutical industry heavyweights Novartis and Bayer are challenging a proposal by parts of the UK’s National Health Service (NHS) to allow patients with wet age...
